Use of gp130 activators in diabetic neuropathy

Details Use of gp130 activators in diabetic neuropathy Use of gp130 activators in diabetic neuropathy

A - Human Necessities

61

K

A61K 38/17 (2006.01) A61K 31/7088 (2006.01) A61K 35/12 (2006.01) A61K 38/20 (2006.01) A61K 47/48 (2006.01) A61K 48/00 (2006.01) A61P 25/02 (2006.01) C07K 19/00 (2006.01)

Patent

CA 2463020

The invention relates to the use a substance signaling through gp130 for the manufacture of a medicament for the treatment and/or prevention of diabetic neuropathy. The use of IL-6 is preferred.

L'invention concerne l'utilisation d'une substance de signalisation par l'intermédiaire de gp130 pour la fabrication d'un médicament destiné au traitement et/ou à la prévention de la neuropathie diabétique. De préférence, IL-6 est utilisé.

Affiliated with

Also associated with

Rating

Use of gp130 activators in diabetic neuropathy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of gp130 activators in diabetic neuropathy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of gp130 activators in diabetic neuropathy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1575435